Suchergebnisse - "Mahdy, Hazem A"

PubPharm (41)

1

New thiazolidine-2,4-diones as potential anticancer agents and apoptotic inducers targeting VEGFR-2 kinase : Design, synthesis, in silico and in vitro studies

enthalten in: Biochimica et biophysica acta. General subjects | 2024

von Elkady, H. | Mahdy, H. | Taghour, M. | +10

2

Semi-synthesized anticancer theobromine derivatives targeting VEGFR-2 : in silico and in vitro evaluations

enthalten in: Journal of biomolecular structure & dynamics | 2024

von Dahab, M. | Mahdy, H. | Elkady, H. | +9

3

Discovery of new thiazolidine-2,4-dione derivatives as potential VEGFR-2 inhibitors : In vitro and in silico studies

enthalten in: Heliyon | 2024

von Eissa, I. | Elkady, H. | Rashed, M. | +10

4

Novel Thiazolidine‐2,4‐Dione Derivatives as Potential VEGFR‐2 Inhibitors : Synthesis, Biological Testing, and in Silico Studies

enthalten in: ChemistrySelect | 2024

von Eissa, I. | Elkady, H. | Taghour, M. | +11

5

New thiazolidine-2,4-diones as effective anti-proliferative and anti-VEGFR-2 agents : Design, synthesis, in vitro, docking, MD simulations, DFT, ADMET, and toxicity studies

enthalten in: Computational biology and chemistry | 2023

von Elkady, H. | Abuelkhir, A. | Rashed, M. | +10

6

Rationale design and synthesis of new apoptotic thiadiazole derivatives targeting VEGFR-2 : computational and in vitro studies

enthalten in: RSC advances | 2023

von Elgammal, W. | Elkady, H. | Mahdy, H. | +7

7

Synthesis, biological evaluation and computer-aided discovery of new thiazolidine-2,4-dione derivatives as potential antitumor VEGFR-2 inhibitors

enthalten in: RSC advances | 2023

von Elkady, H. | El-Dardir, O. | Elwan, A. | +11

8

Design, Synthesis, and Biological Evaluation of New Potential Unusual Modified Anticancer Immunomodulators for Possible Non-Teratogenic Quinazoline-Based Thalidomide Analogs

enthalten in: International journal of molecular sciences | 2023

von Mabrouk, R. | Abdallah, A. | Mahdy, H. | +7

9

Design, synthesis, in silico studies, and biological evaluation of novel pyrimidine-5-carbonitrile derivatives as potential anti-proliferative agents, VEGFR-2 inhibitors and apoptotic inducers

enthalten in: RSC advances | 2023

von Saleh, A. | Mahdy, H. | El-Zahabi, M. | +3

10

New theobromine derivatives inhibiting VEGFR-2 : design, synthesis, antiproliferative, docking and molecular dynamics simulations

enthalten in: Future medicinal chemistry | 2023

von Mahdy, H. | Elkady, H. | Taghour, M. | +9

1
2
3
4
5
Nächster »
[5]